In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseases

Archives of Dermatological Research

Volumn 292, Issue 9, 2000, Pages 472-474

  Alaibac, M ^a   Belloni Fortina, A ^a   Poletti, A ^a   Vandenberghe, P ^b   Marino, F ^a   Tarantello, M ^a   Peserico, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b University of Leuven   (Belgium)

Author keywords

Costimulatory molecules; CTLA 4; Lichen planus; Skin immunology; T lymphocytes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; DNA LIBRARY; IMMUNOLOGY; INFLAMMATION; LICHEN PLANUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033790274     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000161     Document Type: Article

References (11)

1. A new member of the immuno-globulin superfamily: CTLA-4
2. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
3. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
4. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
5. Role of the CD28 receptor during T cell responses to antigen
6. Role of the CTLA-4 receptor in T cell activation and immunity
7. Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases
8. Accumulation of CTLA-4 expressing T lymphocytes in the germinal centers of human lymphoid tissues
9. Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease
10. In vivo expression of the CTLA-4 inhibitor receptor in malignant and reactive cells from human lymphomas
11. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4